Open AccessM2BPGi for assessing liver fibrosis in patients with hepatitis C treated with direct-acting antivirals
Author(s) -
Shereen A. Saleh,
Mohamed Magdy Salama,
Marwan M Alhusseini,
Ghada Mohamed
Publication year - 2020
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v26.i21.2864
Subject(s) - liver fibrosis , hepatitis c , medicine , fibrosis , virology , gastroenterology
Assessing liver fibrosis is important for predicting the efficacy of direct-acting antivirals (DAAs) and patient prognosis. Non-invasive techniques to assess liver fibrosis are becoming important. Recently, serum Mac-2 binding protein glycosylation isomer (M2BPGi) was identified as a non-invasive marker of liver fibrosis.